Article, see p 1865 T he relative merits of off-pump versus on-pump coronary artery bypass grafting (CABG) have been debated in the surgical literature for >25 years. Between 2003 and 2008, 3 large prospective randomized controlled clinical trials (comprising a total of 9494 patients) were initiated: the ROOBY trial (Randomized On/Off Bypass), the CORONARY trial (CABG Off or On Pump Revascularization Study), and the GOPCABE trial (German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients). In this issue of Circulation, Diegeler et al 1 report the outcome of the GOPCABE trial, the last of the 3 studies to reach the 5-year mark.
4
The critical role of surgeons' experience in OPCAB has been repeatedly emphasized by experts in the field and recently demonstrated using registry data and a meta-analytic approach. In an analysis of the Nationwide Inpatient Sample including >2 million patients, Benedetto et al 5 reported that OPCAB reduces operative mortality when performed by surgeons in high-volume OPCAB centers but is associated with increased operative risk in the hands of low-volume surgeons and in-low volume centers. In surgical trials, a lack of experience and comfort with the experimental technique will typically result in a high crossover rate to the control arm. In fact, the crossover rate from the OPCAB group was 7.9% and 9.7% in CORONARY and GOPCABE, respectively, versus 12.4% in ROOBY. In the largest randomized controlled trial meta-analysis of OPCAB versus ONCAB to date (104 trials, 30 915 patients), we showed that a difference in survival in favor of ONCAB is found only in the studies with a crossover rate ≥10%, a rate that may be con- sidered a surrogate marker for a lack of surgical proficiency with OPCAB techniques. 5 This is consistent with meta-analytic data 6 and the results of the recent ART trial (Arterial Revascularization Trial), 7 both suggesting a specific volume-to-outcome effect for complex CABG interventions such as bilateral internal thoracic artery grafting. In the ART, conducted by experienced coronary bypass surgeons, 40% of operations were performed off-pump and with a crossover rate to ONCAB of only 2%, demonstrating that very low conversion rates are achievable by expert surgical teams. Crossover not only dilutes the potential treatment effect, but, as a marker for lack of surgical proficiency, also suggests suboptimal treatment delivery even in patients who did not cross over. In fact, large single-center series performed by experienced operators have consistently reported similar results with the 2 techniques. In 2016, Kirmani and colleagues published a 15-year follow-up of >13 000 propensity-matched patients who had undergone either procedure in the hands of highly experienced operators and showed superimposed survival curves. 8 Two additional issues should be considered in evaluating the relative merit of OPCAB. First, the rationale for OPCAB is that avoidance of cardiopulmonary bypass may reduce the operative risk, especially in complex and frail patients. In retrospective series, it has been shown that the beneficial effect of OPCAB is evident mainly in higher-risk patients and increases with an increasing preoperative risk score. 9 It is therefore somewhat disappointing that the largest comparative randomized controlled trials (RCTs) enrolled relatively low-risk populations: in CORONARY, only 18% of the patients had an EuroScore >5 (predicted mortality 2.9%); ROOBY included patients with preserved ejection fraction and estimated risk of death at 30 days of <2%; and in GOP-CABE, the mean EuroScore of 8.3 was mainly driven by age (67% of the patients had a preoperative ejection fraction >50%). OPCAB has been shown in larger registry series to be most beneficial for patients at the highest risk for morbidity and mortality after CABG. 10, 11 Second, OPCAB surgical techniques have evolved and improved significantly since the conduct of these 3 large RCTs. Specifically, the large majority of OPCAB cases in these 3 large RCTs were performed with a single internal thoracic artery graft to the left anterior descending coronary artery plus multiple saphenous vein grafts sutured to the ascending aorta by using a side-biting clamp, typically placed on the pulsatile aorta without intraoperative epiaortic ultrasound. This technique might be characterized as OPCAB 1.0. Such manipulation of the ascending aorta has been associated with a higher risk of perioperative stroke and death. 12 Moreover, a relative hypercoagulable state may exist after OPCAB in comparison with ONCAB and may impact saphenous vein graft patency. Dual antiplatelet therapy, reported to improve saphenous vein graft patency 13 and now routine after OPCAB, was much less commonly administered when these 3 large RCTs were conducted. Subsequent improvements in OPCAB surgical technique have included clampless OPCAB, in which no clamp is applied to the ascending aorta and proximal anastomoses are constructed with nonclamping devices, such as the Heartstring device, that allow an anastomosis(es) to be sewn to the ascending aorta without aortic clamping. Deployment of these devices is guided by epiaortic ultrasound, which is used to identify atherosclerosis of the ascending aorta to allow individualized management. Clampless OPCAB has been shown to reduce the risk of perioperative stroke and early postoperative mortality in comparison with OPCAB performed with an aortic clamp 12 and may be thought of as OPCAB 2.0. More recently, all-arterial and clampless techniques have been successfully combined by skilled OPCAB surgeons to yield anaortic or no-aortic touch OPCAB performed with exclusively arterial conduits. This technique has been shown in several large nonrandomized clinical series to be associated with a significant decrease in perioperative stroke and major adverse cardiac and cerebrovascular events. 12 This latest enhancement may be considered OPCAB 3.0 and is perhaps the present gold standard for surgical coronary revascularization. In a recent report by Albert et al, 14 comprehensive routine adoption of OPCAB 3.0 techniques led to a decrease in early postoperative stroke from 0.83% to 0.09% among 4485 consecutive patients in a large cardiac surgical department. Observational series and a metaanalysis of 13 studies and 37 720 patients have reported a significant reduction in the risk of perioperative stroke in comparison with both ONCAB and traditional OPCAB using anaortic CABG. 12 See the Figure, in which anaortic OPCAB is shown to be superior to all other techniques in reducing the risk of perioperative death, stroke, and myocardial infarction. Indeed, anaortic CABG carries a class I recommendation in the 2018 European Guidelines on myocardial revascularization. 15 It is regrettable that OPCAB 3.0 (anaortic, all-arterial OP-CAB) is a technically demanding procedure that is only slowly being embraced as a routine practice by genuine coronary surgical specialists.
After 30 years and >100 RCTs, what can be confidently said about the OPCAB controversy? First, both OPCAB and ONCAB procedures have excellent shortterm outcomes with low mortality when performed by experienced surgeons. Second, as shown in the CORO-NARY and GOPCABE trials, in experienced hands, both techniques assure similar midterm survival. Retrospective studies have shown that avoidance of cardiopulmonary bypass and aortic manipulation reduces the risk of stroke and operative mortality in high-risk patients. As the population of the developed world ages and the prevalence of diabetes mellitus and coronary artery disease continues to increase, surgical coronary revascularization will remain a vital and common therapy. It is critically important that we continuously refine our techniques for surgical coronary revascularization, both on-pump and off-pump, to better serve these patients with complex comorbidities.
The above considerations lead inexorably to the conclusion that surgical coronary revascularization should be viewed as a subspecialty of adult cardiac surgery and should be the province of specially trained and dedicated coronary surgical teams. The improvements that have been achieved over the past 20 years in outcomes after mitral and aortic surgery are largely attributable to the care of these patients by dedicated specialty surgeons/teams in high-volume centers. The development of coronary surgical specialists may be necessary to routinely utilize multiple arterial conduits and to minimize aortic manipulation. Off-pump techniques, performed by expert coronary surgical specialists, will likely play an important part in this evolution toward optimal outcomes for all patients. 
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